[EN] COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION<br/>[FR] COMPOSÉS DESTINÉS À LA RÉDUCTION DE LA PRODUCTION DE BÊTA-AMYLOÏDES
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2012162334A1
公开(公告)日:2012-11-29
Compounds of formula (I), including pharmaceutically acceptable salts thereof, are set forth herein: wherein R1, R2, R3, R4, R5, and R6 are independently hydrogen, C1-C6 alkyl or C1-C6 cycloalkyl; Y and Z are independently a C6-C10- aryl group or a 5-10 membered heterocyclic group, wherein each Y and Z group can be optionally substituted with from 0-3 substituents selected from halogen, amino, C1-4alkylamino, C1-4dialkylamino, haloC1-4 alkyl, OH, CN, C1-C6 alkyl or cycloalkyl, C1-C6 alkoxy, and C2-C4 alkynyl; L is either a bond or is -NHCO-; L and Z together can be absent; and m is 1, 2 or 3.
化合物的化学式(I),包括其药用可接受盐,如下所示:其中R1、R2、R3、R4、R5和R6独立地是氢、C1-C6烷基或C1-C6环烷基;Y和Z独立地是C6-C10芳基或5-10成员杂环基,其中每个Y和Z基可以选择地被0-3个取代基取代,所述取代基选自卤素、氨基、C1-4烷基氨基、C1-4二烷基氨基、卤代C1-4烷基、羟基、氰基、C1-C6烷基或环烷基、C1-C6烷氧基和C2-C4炔基;L要么是一个键,要么是-NHCO-;L和Z可以一起不存在;m为1、2或3。